Why Bausch Health Companies Shares Are Falling After Q1 Results
Portfolio Pulse from Nabaparna Bhattacharya
Bausch Health Companies Inc. (NYSE:BHC) shares fell after reporting Q1 results that missed analysts' expectations. The company's adjusted EPS was 59 cents, below the expected 72 cents, and sales were $2.153 billion, slightly missing the $2.156 billion forecast. Despite this, sales increased by 11% on a reported basis and 8% on an organic basis, with notable growth in the Bausch + Lomb and Solta Medical segments. The company reaffirmed its 2024 revenue and adjusted EBITDA outlook.
May 02, 2024 | 5:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bausch Health Companies Inc. shares declined due to Q1 earnings and sales missing expectations, despite reporting growth in several segments.
The immediate negative reaction in BHC's stock price is directly tied to the company's Q1 earnings and sales not meeting analyst expectations. Despite the overall growth in sales and a positive outlook for 2024, the short-term impact is negative due to the earnings miss. Investors often react to earnings misses by selling off shares, leading to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100